The development and initial validation of the Russian version of the BASIS-24

dc.contributor.authorMadden, Lynn
dc.contributor.authorFarnum, Scott
dc.contributor.authorBromberg, Daniel
dc.contributor.authorBarry, Declan
dc.contributor.authorMazhnaya, Alyona
dc.contributor.authorFomenko, Tetiana
dc.contributor.authorMeteliuk, Anna
dc.contributor.authorMarcus, Ruthanne
dc.contributor.authorRozanova, Julia
dc.contributor.authorPoklad, Iurii
dc.contributor.authorDvoriak, Sergii
dc.contributor.authorAltice, Frederick
dc.date.accessioned2023-01-04T08:40:18Z
dc.date.available2023-01-04T08:40:18Z
dc.date.issued2022
dc.description.abstractBackground: Efficient and linguistically appropriate instruments are needed to assess response to addiction treatment, including severity of addiction/mental health status. This is critical for Russian-speaking persons in Eastern Europe and Central Asia (EECA) where Medications for Opioid Use Disorder (MOUD) remain underscaled to address expanding and intertwined opioid, HIV, HCV and tuberculosis epidemics. We developed and conducted a pilot validation of a Russian version of the 24-item Behavior and Symptom Identification Scale (BASIS-24), an addiction/mental health severity instrument with six subscales, previously validated in English. Methods: Using the Mapi approach, we reviewed, translated, and back-translated the content to Russian, pilot-tested the Russian-version (BASIS-24-R) among new MOUD patients in Ukraine (N = 283). For a subset of patients (n = 44), test-rest was performed 48 h after admission to reassess reliability of BASIS-24-R. Exploratory principal component analysis (PCA) assessed underlying structure of BASIS-24-R. Results: Cronbach alpha coefficients for overall BASIS-24-R and 5 subscales exceeded 0.65; coefficient for Relationship subscale was 0.42. The Pearson correlation coefficients for overall score and all subscales on the BASIS-24-R exceeded 0.8. Each item loaded onto factors that corresponded with English BASIS-24 subscales ≥ 0.4 in PCA. Conclusion: Initial version of BASIS-24-R appears statistically valid in Russian. Use of the BASIS-24-R has potential to guide MOUD treatment delivery in the EECA region and help to align addiction treatment with HIV prevention goals in a region where HIV is concentrated in people who inject opioids and where healthcare professionals have not traditionally perceived MOUD as effective treatment, particularly for those with mental health co-morbidities.en_US
dc.identifier.citationThe development and initial validation of the Russian version of the BASIS-24 / Lynn M. Madden, Scott O. Farnum, Daniel J. Bromberg, Declan T. Barry, Alyona Mazhnaya, Tetiana Fomenko, Anna Meteliuk, Ruthanne Marcus, Julia Rozanova, Iurii Poklad, Sergii Dvoriak, Frederick L. Altice // Addiction Science and Clinical Practice. - 2022. - Vol. 17, Issue 1. - Article number 65. - P. 1-7. - https://doi.org/10.1186/s13722-022-00343-0en_US
dc.identifier.issn1940-0632
dc.identifier.urihttps://ekmair.ukma.edu.ua/handle/123456789/24456
dc.identifier.urihttps://doi.org/10.1186/s13722-022-00343-0
dc.language.isoenuk_UA
dc.relation.sourceAddiction Science and Clinical Practiceen_US
dc.statusfirst publisheduk_UA
dc.subjectmedications for Opioid Use Disorder (MOUD)en_US
dc.subjectEastern Europe and Central Asia (EECA)en_US
dc.subjectHIVen_US
dc.subjectBASIS-24-Ren_US
dc.subjectPWIDen_US
dc.subjectimplementation Scienceen_US
dc.subjectvalidationen_US
dc.subjectarticleen_US
dc.titleThe development and initial validation of the Russian version of the BASIS-24en_US
dc.typeArticleuk_UA
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
The_development_and_initial_validation_of_the_Russian_version_of_the_BASIS-24.pdf
Size:
656.92 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
7.54 KB
Format:
Item-specific license agreed upon to submission
Description: